Ronald G. Hall

1.8k total citations
73 papers, 1.3k citations indexed

About

Ronald G. Hall is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Ronald G. Hall has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 22 papers in Pharmacology and 19 papers in Epidemiology. Recurrent topics in Ronald G. Hall's work include Antibiotics Pharmacokinetics and Efficacy (21 papers), Antimicrobial Resistance in Staphylococcus (18 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Ronald G. Hall is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (21 papers), Antimicrobial Resistance in Staphylococcus (18 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Ronald G. Hall collaborates with scholars based in United States, South Africa and United Kingdom. Ronald G. Hall's co-authors include Tawanda Gumbo, David S. Burgess, Richard D. Leff, Anthony J. Busti, Sara D. Brouse, Mark A. Swancutt, Claudia Meek, David M. Margolis, Christopher Giuliano and Krystal K. Haase and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ronald G. Hall

73 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ronald G. Hall

Since Specialization

Citations

This map shows the geographic impact of Ronald G. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Hall more than expected).

Fields of papers citing papers by Ronald G. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald G. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Hall. The network helps show where Ronald G. Hall may publish in the future.

Co-authorship network of co-authors of Ronald G. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald G. Hall. A scholar is included among the top collaborators of Ronald G. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald G. Hall. Ronald G. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Retrospective Analysis of Intravenous Push versus Extended Infusion Meropenem in Critically Ill Patients 2024 ·Antibiotics ·(unknown), (unknown), (unknown), (unknown), Andrew C. Faust, Hui Yang, Carlos A. Álvarez, Ronald G. Hall	2
2	Impact of PCV13 and PPSV23 Vaccination on Invasive Pneumococcal Disease in Adults with Treated Rheumatoid Arthritis: A Population-Based Study 2024 ·Microorganisms ·Carlos A. Álvarez, Ronald G. Hall, (unknown), (unknown), Eric M. Mortensen	1
3	Evaluation of Dose Requirements Using Weight-Based versus Non-Weight-Based Dosing of Norepinephrine to Achieve a Goal Mean Arterial Pressure in Patients with Septic Shock 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Ronald G. Hall	1
4	Evaluation of Scholarship Motivators and Barriers for Non-Tenure-Track Faculty in a Department of Pharmacy Practice 2023 ·SHILAP Revista de lepidopterología ·(unknown), Theresa Byrd, Eric J. MacLaughlin, Ronald G. Hall	5
5	Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review 2023 ·Microorganisms ·(unknown), Kelly R. Reveles, Ronald G. Hall, (unknown), Carlos A. Álvarez	14
6	Insufficient Representation of Patients With Obesity in Randomized Controlled Trials Evaluating the Efficacy and Safety of Antimicrobials for Treatment of Skin and Skin Structure Infections: A Scoping Review 2023 ·Open Forum Infectious Diseases ·(unknown), Jamie L. Wagner, (unknown), (unknown), (unknown), (unknown), (unknown), Ronald G. Hall	1
7	Using the HyFlex model to deliver a capstone seminar course 2022 ·Currents in Pharmacy Teaching and Learning ·(unknown), (unknown), (unknown), (unknown), William C. Putnam, Ronald G. Hall, Steven E. Pass, Eric J. MacLaughlin	3
8	Characterization and compensation of inhomogeneity artifact in spiral hyperpolarized¹³C imaging of the human heart 2021 ·Magnetic Resonance in Medicine ·Galen D. Reed, Junjie Ma, Jae Mo Park, Rolf F. Schulte, Crystal Harrison, Albert P. Chen, (unknown), (unknown), (unknown), (unknown), Jaffar Ali Raza, (unknown), Ronald G. Hall, A. Dean Sherry, Vlad G. Zaha, Craig R. Malloy	9
9	Pharmacists Without Access to the EHR: Practicing with One Hand Tied Behind Our Backs 2021 ·SHILAP Revista de lepidopterología ·(unknown), Ronald G. Hall	5
10	Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety 2021 ·SHILAP Revista de lepidopterología ·W. Anthony Hawkins, Susan Smith, (unknown), (unknown), (unknown), Ronald G. Hall	2
11	A review of citalopram dose restrictions in the treatment of neuropsychiatric disorders in older adults 2019 ·Mental Health Clinician ·(unknown), (unknown), (unknown), (unknown), (unknown), Ronald G. Hall, (unknown)	7
12	Treatment of community-acquired pneumonia 2015 ·Expert Review of Anti-infective Therapy ·Young R. Lee, (unknown), Ronald G. Hall	8
13	Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections 2015 ·Infection and Drug Resistance ·Ronald G. Hall, (unknown)	14
14	Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study 2013 ·BMC Pharmacology and Toxicology ·Ronald G. Hall, (unknown), Sara D. Brouse, Christopher Giuliano, Krystal K. Haase, Christopher R. Frei, (unknown), (unknown), Roger Bedimo, Carlos A. Álvarez	43
15	Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination? 2010 ·The American Journal of Medicine ·(unknown), Sara D. Brouse, (unknown), Ronald G. Hall	117
16	Tracheal intubation in the emergency department: the Scottish district hospital perspective 2007 ·Emergency Medicine Journal ·(unknown), Colin A. Graham, Ronald G. Hall, (unknown), (unknown)	43
17	Simulated Comparison of the Pharmacodynamics of Ciprofloxacin and Levofloxacin Against Pseudomonas aeruginosa Using Pharmacokinetic Data from Healthy Volunteers and 2002 Minimum Inhibitory Concentration Data 2007 ·Clinical Therapeutics ·David S. Burgess, Ronald G. Hall	13
18	In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-esbl producing klebsiella pneumoniae 2004 ·Diagnostic Microbiology and Infectious Disease ·David S. Burgess, Ronald G. Hall	61
19	In vitro activity of parenteral β-lactams, levofloxacin and tobramycin alone or in combination against extended-spectrum β-lactamase producing Klebsiella pneumoniae 2004 ·International Journal of Antimicrobial Agents ·David S. Burgess, Ronald G. Hall	1
20	Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period 2003 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·David S. Burgess, Ronald G. Hall, James S. Lewis, James H. Jorgensen, Jan E. Patterson	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact